{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:18:45Z","timestamp":1794845925616,"version":"4.9.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chaire DesGroseillers-Berard en Cardiologie Interventionnelle"},{"name":"Chaire fondation Marcelle et Jean Coutu en insuffisance cardiaque"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the past decade, despite key advances in therapeutic strategies following myocardial infarction, none can directly address the loss of cardiomyocytes following ischemic injury. Cardiac cell-based therapy is at the cornerstone of regenerative medicine that has shown potential for tissue repair. Mesenchymal stem cells (MSC) represent a strong candidate to heal the infarcted myocardium. While differentiation potential has been described as a possible avenue for MSC-based repair, their secreted mediators are responsible for the majority of the ascribed prohealing effects. MSC can either promote their own survival and proliferation through autocrine effect or secrete trophic factors that will act on adjacent cells through a paracrine effect. Prior studies have also documented beneficial effects even when MSCs were remotely delivered, much akin to an endocrine mechanism. This review aims to distinguish the paracrine activity of MSCs from an endocrine-like effect, where remotely transplanted cells can promote healing of the injured myocardium.<\/jats:p>","DOI":"10.1186\/s12967-020-02504-8","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T11:03:51Z","timestamp":1598958231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Mesenchymal stem cell mediates cardiac repair through autocrine, paracrine and endocrine axes"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-6225","authenticated-orcid":false,"given":"Celia","family":"Sid-Otmane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis P.","family":"Perrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung Q.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"issue":"1","key":"2504_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","volume":"70","author":"GA Roth","year":"2017","unstructured":"Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1\u201325.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2504_CR2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/stem.2778","volume":"36","author":"R Wu","year":"2018","unstructured":"Wu R, Hu X, Wang J. Concise review: optimized strategies for stem cell-based therapy in myocardial repair: clinical translatability and potential limitation. Stem Cells. 2018;36(4):482\u2013500.","journal-title":"Stem Cells"},{"issue":"7","key":"2504_CR3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.117.029343","volume":"136","author":"T Eschenhagen","year":"2017","unstructured":"Eschenhagen T, Bolli R, Braun T, Field LJ, Fleischmann BK, Frisen J, et al. Cardiomyocyte regeneration: a consensus statement. Circulation. 2017;136(7):680\u20136.","journal-title":"Circulation"},{"issue":"4","key":"2504_CR4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biotechadv.2018.03.011","volume":"36","author":"L Bacakova","year":"2018","unstructured":"Bacakova L, Zarubova J, Travnickova M, Musilkova J, Pajorova J, Slepicka P, et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells\u2014a review. Biotechnol Adv. 2018;36(4):1111\u201326.","journal-title":"Biotechnol Adv"},{"issue":"3","key":"2504_CR5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.18388\/abp.2015_1023","volume":"62","author":"J Dulak","year":"2015","unstructured":"Dulak J, Szade K, Szade A, Nowak W, Jozkowicz A. Adult stem cells: hopes and hypes of regenerative medicine. Acta Biochim Pol. 2015;62(3):329\u201337.","journal-title":"Acta Biochim Pol"},{"issue":"4","key":"2504_CR6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"2","key":"2504_CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi Y, Inoue H, Wu JC, Yamanaka S. Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov. 2017;16(2):115\u201330.","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"2504_CR8","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2217\/imt-2016-0098","volume":"8","author":"J Girdlestone","year":"2016","unstructured":"Girdlestone J. Mesenchymal stromal cells with enhanced therapeutic properties. Immunotherapy. 2016;8(12):1405\u201316.","journal-title":"Immunotherapy"},{"issue":"4","key":"2504_CR9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tibtech.2006.01.010","volume":"24","author":"JK Fraser","year":"2006","unstructured":"Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 2006;24(4):150\u20134.","journal-title":"Trends Biotechnol"},{"issue":"8","key":"2504_CR10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493\u2013507.","journal-title":"Nat Rev Nephrol"},{"key":"2504_CR11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev-cellbio-100913-013132","volume":"30","author":"P Bianco","year":"2014","unstructured":"Bianco P. \u201cMesenchymal\u201d stem cells. Annu Rev Cell Dev Biol. 2014;30:677\u2013704.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"3","key":"2504_CR12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbrc.2007.01.045","volume":"354","author":"Y Iso","year":"2007","unstructured":"Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, Song YH, et al. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun. 2007;354(3):700\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2504_CR13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.stem.2012.02.005","volume":"10","author":"SH Ranganath","year":"2012","unstructured":"Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012;10(3):244\u201358.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"2504_CR14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12265-010-9198-2","volume":"3","author":"S Maltais","year":"2010","unstructured":"Maltais S, Tremblay JP, Perrault LP, Ly HQ. The paracrine effect: pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res. 2010;3(6):652\u201362.","journal-title":"J Cardiovasc Transl Res"},{"issue":"22","key":"2504_CR15","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;308(22):2369\u201379.","journal-title":"JAMA"},{"issue":"1","key":"2504_CR16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ahj.2014.03.022","volume":"168","author":"EC Perin","year":"2014","unstructured":"Perin EC, Sanz-Ruiz R, Sanchez PL, Lasso J, Perez-Cano R, Alonso-Farto JC, et al. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: the PRECISE trial. Am Heart J. 2014;168(1):88\u201395.e2.","journal-title":"Am Heart J"},{"issue":"8","key":"2504_CR17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.116.303614","volume":"116","author":"V Karantalis","year":"2015","unstructured":"Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;116(8):1413\u201330.","journal-title":"Circ Res"},{"issue":"7","key":"2504_CR18","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ymthe.2018.05.009","volume":"26","author":"L Bagno","year":"2018","unstructured":"Bagno L, Hatzistergos KE, Balkan W, Hare JM. Mesenchymal stem cell-based therapy for cardiovascular disease: progress and challenges. Mol Ther. 2018;26(7):1610\u201323.","journal-title":"Mol Ther"},{"issue":"2","key":"2504_CR19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","volume":"7","author":"PA Zuk","year":"2001","unstructured":"Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211\u201328.","journal-title":"Tissue Eng"},{"key":"2504_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/713959","volume":"2013","author":"P Zuk","year":"2013","unstructured":"Zuk P. Adipose-derived stem cells in tissue regeneration: a review. ISRN Stem Cells. 2013;2013:1\u201335.","journal-title":"ISRN Stem Cells"},{"issue":"9","key":"2504_CR21","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/sctm.17-0031","volume":"6","author":"NM Toyserkani","year":"2017","unstructured":"Toyserkani NM, Jorgensen MG, Tabatabaeifar S, Jensen CH, Sheikh SP, Sorensen JA. Concise review: a safety assessment of adipose-derived cell therapy in clinical trials: a systematic review of reported adverse events. Stem Cells Transl Med. 2017;6(9):1786\u201394.","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"2504_CR22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.0000114522.38265.61","volume":"109","author":"V Planat-Benard","year":"2004","unstructured":"Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004;109(5):656\u201363.","journal-title":"Circulation"},{"issue":"3","key":"2504_CR23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0003-4975(02)04568-X","volume":"75","author":"S Rangappa","year":"2003","unstructured":"Rangappa S, Fen C, Lee EH, Bongso A, Sim EK. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg. 2003;75(3):775\u20139.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"2504_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijcard.2007.11.068","volume":"133","author":"WC Lee","year":"2009","unstructured":"Lee WC, Sepulveda JL, Rubin JP, Marra KG. Cardiomyogenic differentiation potential of human adipose precursor cells. Int J Cardiol. 2009;133(3):399\u2013401.","journal-title":"Int J Cardiol"},{"issue":"13","key":"2504_CR25","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1016\/j.biomaterials.2014.01.021","volume":"35","author":"H Wang","year":"2014","unstructured":"Wang H, Shi J, Wang Y, Yin Y, Wang L, Liu J, et al. Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction. Biomaterials. 2014;35(13):3986\u201398.","journal-title":"Biomaterials"},{"issue":"1","key":"2504_CR26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/eci.12195","volume":"44","author":"M Rigol","year":"2014","unstructured":"Rigol M, Solanes N, Roura S, Roque M, Novensa L, Dantas AP, et al. Allogeneic adipose stem cell therapy in acute myocardial infarction. Eur J Clin Invest. 2014;44(1):83\u201392.","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"2504_CR27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1172\/JCI200522326","volume":"115","author":"YS Yoon","year":"2005","unstructured":"Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, Kusano K, et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest. 2005;115(2):326\u201338.","journal-title":"J Clin Invest"},{"issue":"21","key":"2504_CR28","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/eurheartj\/ehm426","volume":"28","author":"C Valina","year":"2007","unstructured":"Valina C, Pinkernell K, Song YH, Bai X, Sadat S, Campeau RJ, et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J. 2007;28(21):2667\u201377.","journal-title":"Eur Heart J"},{"issue":"5","key":"2504_CR29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/stem.632","volume":"29","author":"A Acquistapace","year":"2011","unstructured":"Acquistapace A, Bru T, Lesault PF, Figeac F, Coudert AE, le Coz O, et al. Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells. 2011;29(5):812\u201324.","journal-title":"Stem Cells"},{"issue":"4","key":"2504_CR30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/eurheartj\/ehp568","volume":"31","author":"X Bai","year":"2010","unstructured":"Bai X, Yan Y, Song YH, Seidensticker M, Rabinovich B, Metzele R, et al. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J. 2010;31(4):489\u2013501.","journal-title":"Eur Heart J"},{"issue":"8","key":"2504_CR31","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3727\/096368911X627462","volume":"21","author":"J Otto Beitnes","year":"2012","unstructured":"Otto Beitnes J, Oie E, Shahdadfar A, Karlsen T, Muller RM, Aakhus S, et al. Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function. Cell Transplant. 2012;21(8):1697\u2013709.","journal-title":"Cell Transplant"},{"issue":"3","key":"2504_CR32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1634\/stemcells.2008-0886","volume":"27","author":"G Duque","year":"2009","unstructured":"Duque G, Huang DC, Macoritto M, Rivas D, Yang XF, Ste-Marie LG, et al. Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells. 2009;27(3):550\u20138.","journal-title":"Stem Cells"},{"issue":"6","key":"2504_CR33","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1634\/stemcells.2007-0480","volume":"26","author":"DA Rider","year":"2008","unstructured":"Rider DA, Dombrowski C, Sawyer AA, Ng GH, Leong D, Hutmacher DW, et al. Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells. 2008;26(6):1598\u2013608.","journal-title":"Stem Cells"},{"issue":"2","key":"2504_CR34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jcp.22152","volume":"224","author":"Z Hamidouche","year":"2010","unstructured":"Hamidouche Z, Fromigue O, Nuber U, Vaudin P, Pages JC, Ebert R, et al. Autocrine fibroblast growth factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells. J Cell Physiol. 2010;224(2):509\u201315.","journal-title":"J Cell Physiol"},{"issue":"5","key":"2504_CR35","doi-asserted-by":"crossref","first-page":"e63638","DOI":"10.1371\/journal.pone.0063638","volume":"8","author":"M Hemmingsen","year":"2013","unstructured":"Hemmingsen M, Vedel S, Skafte-Pedersen P, Sabourin D, Collas P, Bruus H, et al. The role of paracrine and autocrine signaling in the early phase of adipogenic differentiation of adipose-derived stem cells. PLoS ONE. 2013;8(5):e63638.","journal-title":"PLoS ONE"},{"issue":"4","key":"2504_CR36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jcb.20462","volume":"95","author":"H Mayer","year":"2005","unstructured":"Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, Weich H. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem. 2005;95(4):827\u201339.","journal-title":"J Cell Biochem"},{"issue":"1","key":"2504_CR37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbrc.2014.01.084","volume":"445","author":"YW Eom","year":"2014","unstructured":"Eom YW, Oh JE, Lee JI, Baik SK, Rhee KJ, Shin HC, et al. The role of growth factors in maintenance of stemness in bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun. 2014;445(1):16\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"2504_CR38","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1096\/fj.14-250159","volume":"28","author":"CA Dumitru","year":"2014","unstructured":"Dumitru CA, Hemeda H, Jakob M, Lang S, Brandau S. Stimulation of mesenchymal stromal cells (MSCs) via TLR3 reveals a novel mechanism of autocrine priming. FASEB J. 2014;28(9):3856\u201366.","journal-title":"FASEB J"},{"key":"2504_CR39","doi-asserted-by":"crossref","first-page":"26298","DOI":"10.1038\/srep26298","volume":"6","author":"BC Lee","year":"2016","unstructured":"Lee BC, Kim HS, Shin TH, Kang I, Lee JY, Kim JJ, et al. PGE2 maintains self-renewal of human adult stem cells via EP2-mediated autocrine signaling and its production is regulated by cell-to-cell contact. Sci Rep. 2016;6:26298.","journal-title":"Sci Rep"},{"issue":"12","key":"2504_CR40","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1161\/01.ATV.0000190701.92007.6d","volume":"25","author":"H Nakagami","year":"2005","unstructured":"Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol. 2005;25(12):2542\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2504_CR41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbrc.2007.09.058","volume":"363","author":"S Sadat","year":"2007","unstructured":"Sadat S, Gehmert S, Song YH, Yen Y, Bai X, Gaiser S, et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun. 2007;363(3):674\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2504_CR42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54\u201363.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2504_CR43","doi-asserted-by":"crossref","first-page":"e005771","DOI":"10.1161\/JAHA.117.005771","volume":"6","author":"J Bobi","year":"2017","unstructured":"Bobi J, Solanes N, Fernandez-Jimenez R, Galan-Arriola C, Dantas AP, Fernandez-Friera L, et al. Intracoronary administration of allogeneic adipose tissue-derived mesenchymal stem cells improves myocardial perfusion but not left ventricle function, in a translational model of acute myocardial infarction. J Am Heart Assoc. 2017;6(5):e005771.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"2504_CR44","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s10529-014-1589-z","volume":"36","author":"X Wang","year":"2014","unstructured":"Wang X, Xi WC, Wang F. The beneficial effects of intracoronary autologous bone marrow stem cell transfer as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction. Biotechnol Lett. 2014;36(11):2163\u20138.","journal-title":"Biotechnol Lett"},{"issue":"1","key":"2504_CR45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2004.03.034","volume":"94","author":"SL Chen","year":"2004","unstructured":"Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004;94(1):92\u20135.","journal-title":"Am J Cardiol"},{"issue":"4","key":"2504_CR46","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.ijcard.2013.04.112","volume":"168","author":"LR Gao","year":"2013","unstructured":"Gao LR, Pei XT, Ding QA, Chen Y, Zhang NK, Chen HY, et al. A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction. Int J Cardiol. 2013;168(4):3191\u20139.","journal-title":"Int J Cardiol"},{"issue":"9819","key":"2504_CR47","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","volume":"379","author":"RR Makkar","year":"2012","unstructured":"Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379(9819):895\u2013904.","journal-title":"Lancet"},{"key":"2504_CR48","doi-asserted-by":"crossref","first-page":"19155","DOI":"10.1038\/srep19155","volume":"6","author":"D Mu","year":"2016","unstructured":"Mu D, Zhang XL, Xie J, Yuan HH, Wang K, Huang W, et al. Intracoronary transplantation of mesenchymal stem cells with overexpressed integrin-linked kinase improves cardiac function in porcine myocardial infarction. Sci Rep. 2016;6:19155.","journal-title":"Sci Rep"},{"issue":"3","key":"2504_CR49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.yjmcc.2007.09.012","volume":"44","author":"EC Perin","year":"2008","unstructured":"Perin EC, Silva GV, Assad JA, Vela D, Buja LM, Sousa AL, et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol. 2008;44(3):486\u201395.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"2504_CR50","doi-asserted-by":"crossref","first-page":"e59020","DOI":"10.1371\/journal.pone.0059020","volume":"8","author":"D Yang","year":"2013","unstructured":"Yang D, Wang W, Li L, Peng Y, Chen P, Huang H, et al. The relative contribution of paracine effect versus direct differentiation on adipose-derived stem cell transplantation mediated cardiac repair. PLoS ONE. 2013;8(3):e59020.","journal-title":"PLoS ONE"},{"issue":"Suppl 2","key":"2504_CR51","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41409-019-0616-z","volume":"54","author":"M Mendt","year":"2019","unstructured":"Mendt M, Rezvani K, Shpall E. Mesenchymal stem cell-derived exosomes for clinical use. Bone Marrow Transplant. 2019;54(Suppl 2):789\u201392.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2504_CR52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00109-013-1110-5","volume":"92","author":"S Bian","year":"2014","unstructured":"Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med. 2014;92(4):387\u201397.","journal-title":"J Mol Med"},{"issue":"6","key":"2504_CR53","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1159\/000438594","volume":"37","author":"X Teng","year":"2015","unstructured":"Teng X, Chen L, Chen W, Yang J, Yang Z, Shen Z. Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation. Cell Physiol Biochem. 2015;37(6):2415\u201324.","journal-title":"Cell Physiol Biochem"},{"key":"2504_CR54","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/srep01197","volume":"3","author":"T Katsuda","year":"2013","unstructured":"Katsuda T, Tsuchiya R, Kosaka N, Yoshioka Y, Takagaki K, Oki K, et al. Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep. 2013;3:1197.","journal-title":"Sci Rep"},{"key":"2504_CR55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuroscience.2016.01.061","volume":"320","author":"MA Lopez-Verrilli","year":"2016","unstructured":"Lopez-Verrilli MA, Caviedes A, Cabrera A, Sandoval S, Wyneken U, Khoury M. Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth. Neuroscience. 2016;320:129\u201339.","journal-title":"Neuroscience"},{"issue":"1","key":"2504_CR56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbrc.2008.06.074","volume":"374","author":"C Nakanishi","year":"2008","unstructured":"Nakanishi C, Yamagishi M, Yamahara K, Hagino I, Mori H, Sawa Y, et al. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun. 2008;374(1):11\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"2504_CR57","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/jcmm.13097","volume":"21","author":"QL Wang","year":"2017","unstructured":"Wang QL, Wang HJ, Li ZH, Wang YL, Wu XP, Tan YZ. Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium. J Cell Mol Med. 2017;21(9):1751\u201366.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2504_CR58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","volume":"4","author":"JM Karp","year":"2009","unstructured":"Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4(3):206\u201316.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2504_CR59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13287-017-0472-y","volume":"8","author":"C Mao","year":"2017","unstructured":"Mao C, Hou X, Wang B, Chi J, Jiang Y, Zhang C, et al. Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats. Stem Cell Res Ther. 2017;8(1):18.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"2504_CR60","doi-asserted-by":"crossref","first-page":"H1888","DOI":"10.1152\/ajpheart.00186.2009","volume":"296","author":"A Shabbir","year":"2009","unstructured":"Shabbir A, Zisa D, Suzuki G, Lee T. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol. 2009;296(6):H1888\u201397.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"2504_CR61","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/stem.1687","volume":"32","author":"MB Preda","year":"2014","unstructured":"Preda MB, Ronningen T, Burlacu A, Simionescu M, Moskaug JO, Valen G. Remote transplantation of mesenchymal stem cells protects the heart against ischemia-reperfusion injury. Stem Cells. 2014;32(8):2123\u201334.","journal-title":"Stem Cells"},{"issue":"5","key":"2504_CR62","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/dmd.111.043604","volume":"40","author":"W Wang","year":"2012","unstructured":"Wang W, Chen N, Shen X, Cunningham P, Fauty S, Michel K, et al. Lymphatic transport and catabolism of therapeutic proteins after subcutaneous administration to rats and dogs. Drug Metab Dispos. 2012;40(5):952\u201362.","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"2504_CR63","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/cr.2008.80","volume":"18","author":"H Sheng","year":"2008","unstructured":"Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, et al. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res. 2008;18(8):846\u201357.","journal-title":"Cell Res"},{"issue":"2","key":"2504_CR64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/stem.1285","volume":"31","author":"CW Chen","year":"2013","unstructured":"Chen CW, Okada M, Proto JD, Gao X, Sekiya N, Beckman SA, et al. Human pericytes for ischemic heart repair. Stem Cells. 2013;31(2):305\u201316.","journal-title":"Stem Cells"},{"key":"2504_CR65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-319-57613-8_5","volume":"1003","author":"T Kennedy-Lydon","year":"2017","unstructured":"Kennedy-Lydon T. Immune functions and properties of resident cells in the heart and cardiovascular system: pericytes. Adv Exp Med Biol. 2017;1003:93\u2013103.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"2504_CR66","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2011.09.065","volume":"59","author":"JH Houtgraaf","year":"2012","unstructured":"Houtgraaf JH, den Dekker WK, van Dalen BM, Springeling T, de Jong R, van Geuns RJ, et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2012;59(5):539\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"2504_CR67","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","volume":"61","author":"J Bartunek","year":"2013","unstructured":"Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol. 2013;61(23):2329\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2504_CR68","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","volume":"114","author":"V Karantalis","year":"2014","unstructured":"Karantalis V, DiFede DL, Gerstenblith G, Pham S, Symes J, Zambrano JP, et al. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial. Circ Res. 2014;114(8):1302\u201310.","journal-title":"Circ Res"},{"key":"2504_CR69","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12916-015-0399-z","volume":"13","author":"LR Gao","year":"2015","unstructured":"Gao LR, Chen Y, Zhang NK, Yang XL, Liu HL, Wang ZG, et al. Intracoronary infusion of Wharton\u2019s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial. BMC Med. 2015;13:162.","journal-title":"BMC Med"},{"issue":"11","key":"2504_CR70","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","volume":"121","author":"V Florea","year":"2017","unstructured":"Florea V, Rieger AC, DiFede DL, El-Khorazaty J, Natsumeda M, Banerjee MN, et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study). Circ Res. 2017;121(11):1279\u201390.","journal-title":"Circ Res"},{"issue":"9","key":"2504_CR71","first-page":"648","volume":"38","author":"J Bartunek","year":"2017","unstructured":"Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, et al. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39\u00a0weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial. Eur Heart J. 2017;38(9):648\u201360.","journal-title":"Eur Heart J"},{"issue":"2","key":"2504_CR72","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ccd.26601","volume":"89","author":"TD Henry","year":"2017","unstructured":"Henry TD, Pepine CJ, Lambert CR, Traverse JH, Schatz R, Costa M, et al. The Athena trials: autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. Catheter Cardiovasc Interv. 2017;89(2):169\u201377.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2504_CR73","doi-asserted-by":"crossref","first-page":"5237063","DOI":"10.1155\/2017\/5237063","volume":"2017","author":"AA Qayyum","year":"2017","unstructured":"Qayyum AA, Mathiasen AB, Mygind ND, Kuhl JT, Jorgensen E, Helqvist S, et al. Adipose-derived stromal cells for treatment of patients with chronic ischemic heart disease (MyStromalCell Trial): a randomized placebo-controlled study. Stem Cells Int. 2017;2017:5237063.","journal-title":"Stem Cells Int"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02504-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-020-02504-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02504-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T20:29:12Z","timestamp":1630441752000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02504-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2504"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02504-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"3 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"336"}}